Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ronald Hines

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Physiology

Anatomy

Concepts & Ideas

Molecular Sequence Data

Living Beings

Rats

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
15
McCarver, Gail
11
Koukouritaki, Sevasti
11
Williams, David
8
Prough, Russell
7
Krueger, Sharon
6
Cabacungan, Erwin
5
Piechocki, Marie
5
Poch, Mark
5
Rettie, Allan
4
Stevens, Jeffrey
3
Schlenk, Daniel
3
Siddens, Lisbeth
3
Phillips, Ian
3
Yost, Garold
3
Yueh, Mei-Fei

Sign-in to see all Coauthors

Publications

TOP 3
Croom Edward L; Stevens Jeffrey C; Hines Ronald N; Wallace Andrew D; Hodgson Ernest
Human hepatic CYP2B6 developmental expression: the impact of age and genotype.
Stevens Jeffrey C; Marsh Sandra A; Zaya Matthew J; Regina Karen J; Divakaran Karthika; Le Min; Hines Ronald N
Developmental changes in human liver CYP2D6 expression.
Klick David E; Shadley Jeff D; Hines Ronald N
Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ronald Hines (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Croom Edward L; Stevens Jeffrey C; Hines Ronald N; Wallace Andrew D; Hodgson Ernest
Human hepatic CYP2B6 developmental expression: the impact of age and genotype.
Biochemical pharmacology 2009;78(2):184-90.
2008: Stevens Jeffrey C; Marsh Sandra A; Zaya Matthew J; Regina Karen J; Divakaran Karthika; Le Min; Hines Ronald N
Developmental changes in human liver CYP2D6 expression.
Drug metabolism and disposition: the biological fate of chemicals 2008;36(8):1587-93.
2008: Klick David E; Shadley Jeff D; Hines Ronald N
Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Biochemical pharmacology 2008;76(2):268-78.
2008: Kramer Melissa A; Rettie Allan E; Rieder Mark J; Cabacungan Erwin T; Hines Ronald N
Novel CYP2C9 promoter variants and assessment of their impact on gene expression.
Molecular pharmacology 2008;73(6):1751-60.
2008: Hines Ronald N
The ontogeny of drug metabolism enzymes and implications for adverse drug events.
Pharmacology & therapeutics 2008;118(2):250-67.
2008: Hines Ronald N; Koukouritaki Sevasti B; Poch Mark T; Stephens Michael C
Regulatory polymorphisms and their contribution to interindividual differences in the expression of enzymes influencing drug and toxicant disposition.
Drug metabolism reviews 2008;40(2):263-301.
2007: Shadley Jeff D; Divakaran Karthika; Munson Kimber; Hines Ronald N; Douglas Kirk; McCarver D Gail
Identification and functional analysis of a novel human CYP2E1 far upstream enhancer.
Molecular pharmacology 2007;71(6):1630-9.
2007: Koukouritaki Sevasti B; Poch Mark T; Henderson Marilyn C; Siddens Lisbeth K; Krueger Sharon K; VanDyke Jonathan E; Williams David E; Pajewski Nicholas M; Wang Tao; Hines Ronald N
Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants.
The Journal of pharmacology and experimental therapeutics 2007;320(1):266-73.
2007: Hines Ronald N
Ontogeny of human hepatic cytochromes P450.
Journal of biochemical and molecular toxicology 2007;21(4):169-75.
2007: Klick David E; Hines Ronald N
Mechanisms regulating human FMO3 transcription.
Drug metabolism reviews 2007;39(2-3):419-42.
2006: Zaya Matthew J; Hines Ronald N; Stevens Jeffrey C
Epirubicin glucuronidation and UGT2B7 developmental expression.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(12):2097-101.
2006: Vyas Piyush M; Roychowdhury Sanjoy; Khan Farah D; Prisinzano Thomas E; Lamba Jatinder; Schuetz Erin G; Blaisdell Joyce; Goldstein Joyce A; Munson Kimber L; Hines Ronald N; Svensson Craig K
Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: I. Expression and role of cytochromes P450.
The Journal of pharmacology and experimental therapeutics 2006;319(1):488-96.
2006: Vyas Piyush M; Roychowdhury Sanjoy; Koukouritaki Sevasti B; Hines Ronald N; Krueger Sharon K; Williams David E; Nauseef William M; Svensson Craig K
Enzyme-mediated protein haptenation of dapsone and sulfamethoxazole in human keratinocytes: II. Expression and role of flavin-containing monooxygenases and peroxidases.
The Journal of pharmacology and experimental therapeutics 2006;319(1):497-505.
2006: Hines Ronald N; McCarver D Gail
Pharmacogenomics and the future of drug therapy.
Pediatric clinics of North America 2006;53(4):591-619.
2006: Yang Feng; Tong Xianping; McCarver D Gail; Hines Ronald N; Beard Daniel A
Population-based analysis of methadone distribution and metabolism using an age-dependent physiologically based pharmacokinetic model.
Journal of pharmacokinetics and pharmacodynamics 2006;33(4):485-518.
2006: Nong A; McCarver D G; Hines R N; Krishnan K
Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: a case study with toluene.
Toxicology and applied pharmacology 2006;214(1):78-87.
2006: Duanmu Zhengbo; Weckle Amy; Koukouritaki Sevasti B; Hines Ronald N; Falany Josie L; Falany Charles N; Kocarek Thomas A; Runge-Morris Melissa
Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre- and postnatal human liver.
The Journal of pharmacology and experimental therapeutics 2006;316(3):1310-7.
2006: Hines Ronald N
Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3.
Expert opinion on drug metabolism & toxicology 2006;2(1):41-9.
2006: Cooper Ralph L; Lamb James C; Barlow Sue M; Bentley Karin; Brady Angela M; Doerrer Nancy G; Eisenbrandt David L; Fenner-Crisp Penelope A; Hines Ronald N; Irvine Lorraine F H; Kimmel Carole A; Koeter Herman; Li Abby A; Makris Susan L; Sheets Larry P; Speijers Gerrit; Whitby Karen E
A tiered approach to life stages testing for agricultural chemical safety assessment.
Critical reviews in toxicology 2006;36(1):69-98.
2006: Krueger Sharon K; Vandyke Jonathan E; Williams David E; Hines Ronald N
The role of flavin-containing monooxygenase (FMO) in the metabolism of tamoxifen and other tertiary amines.
Drug metabolism reviews 2006;38(1-2):139-47.
2005: Koukouritaki Sevasti B; Hines Ronald N
Flavin-containing monooxygenase genetic polymorphism: impact on chemical metabolism and drug development.
Pharmacogenomics 2005;6(8):807-22.
2005: Poch Mark T; Cutler N Shane; Yost Garold S; Hines Ronald N
Molecular mechanisms regulating human CYP4B1 lung-selective expression.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(8):1174-84.
2005: Wan Jie; Carr Brian A; Cutler N Shane; Lanza Diane L; Hines Ronald N; Yost Garold S
Sp1 and Sp3 regulate basal transcription of the human CYP2F1 gene.
Drug metabolism and disposition: the biological fate of chemicals 2005;33(8):1244-53.
2005: Koukouritaki Sevasti B; Poch Mark T; Cabacungan Erwin T; McCarver D Gail; Hines Ronald N
Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants.
Molecular pharmacology 2005;68(2):383-92.
2005: Krueger Sharon K; Siddens Lisbeth K; Henderson Marilyn C; Andreasen Eric A; Tanguay Robert L; Pereira Clifford B; Cabacungan Erwin T; Hines Ronald N; Ardlie Kristin G; Williams David E
Haplotype and functional analysis of four flavin-containing monooxygenase isoform 2 (FMO2) polymorphisms in Hispanics.
Pharmacogenetics and genomics 2005;15(4):245-56.
2004: Krueger Sharon K; Siddens Lisbeth K; Martin Sarah R; Yu Zhen; Pereira Clifford B; Cabacungan Erwin T; Hines Ronald N; Ardlie Kristin G; Raucy Judy L; Williams David E
Differences in FMO2*1 allelic frequency between Hispanics of Puerto Rican and Mexican descent.
Drug metabolism and disposition: the biological fate of chemicals 2004;32(12):1337-40.
2004: Poch Mark T; Al-Kassim Loola; Smolinski Steven M; Hines Ronald N
Two distinct classes of CCAAT box elements that bind nuclear factor-Y/alpha-actinin-4: potential role in human CYP1A1 regulation.
Toxicology and applied pharmacology 2004;199(3):239-50.
2004: Hines Ronald N; Adams Jane; Buck Germaine M; Faber Willem; Holson Joseph F; Jacobson Sandra W; Keszler Martin; McMartin Kenneth; Segraves Robert Taylor; Singer Lynn T; Sipes I Glenn; Williams Paige L
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine.
Birth defects research. Part B, Developmental and reproductive toxicology 2004;71(4):193-280.
2004: Koukouritaki Sevasti B; Manro Jason R; Marsh Sandra A; Stevens Jeffrey C; Rettie Allan E; McCarver D Gail; Hines Ronald N
Developmental expression of human hepatic CYP2C9 and CYP2C19.
The Journal of pharmacology and experimental therapeutics 2004;308(3):965-74.
2003: Stevens Jeffrey C; Hines Ronald N; Gu Chungang; Koukouritaki Sevasti B; Manro Jason R; Tandler Peter J; Zaya Matthew J
Developmental expression of the major human hepatic CYP3A enzymes.
The Journal of pharmacology and experimental therapeutics 2003;307(2):573-82.
2003: Johnsrud Elizabeth K; Koukouritaki Sevasti B; Divakaran Karthika; Brunengraber Laura L; Hines Ronald N; McCarver D Gail
Human hepatic CYP2E1 expression during development.
The Journal of pharmacology and experimental therapeutics 2003;307(1):402-7.
2003: Hines Ronald N
Publication of stand-alone single nucleotide polymorphism (SNP) discovery data.
Drug metabolism and disposition: the biological fate of chemicals 2003;31(9):1073.
2003: Hines Ronald N; Luo Zhaohui; Hopp Kathleen A; Cabacungan Erwin T; Koukouritaki Sevasti B; McCarver D Gail
Genetic variability at the human FMO1 locus: significance of a basal promoter yin yang 1 element polymorphism (FMO1*6).
The Journal of pharmacology and experimental therapeutics 2003;306(3):1210-8.
2003: Cunningham Michael L; Bogdanffy Matthew S; Zacharewski Timothy R; Hines Ronald N
Workshop overview: use of genomic data in risk assessment.
Toxicological sciences : an official journal of the Society of Toxicology 2003;73(2):209-15.
2003: Ou Jingsong; Ou Zhijun; McCarver D Gail; Hines Ronald N; Oldham Keith T; Ackerman Allan W; Pritchard Kirkwood A
Trichloroethylene decreases heat shock protein 90 interactions with endothelial nitric oxide synthase: implications for endothelial cell proliferation.
Toxicological sciences : an official journal of the Society of Toxicology 2003;73(1):90-7.
2003: Lash Lawrence H; Hines Ronald N; Gonzalez Frank J; Zacharewski Timothy R; Rothstein Mark A
Genetics and susceptibility to toxic chemicals: do you (or should you) know your genetic profile?
The Journal of pharmacology and experimental therapeutics 2003;305(2):403-9.
2003: Carr Brian A; Wan Jie; Hines Ronald N; Yost Garold S
Characterization of the human lung CYP2F1 gene and identification of a novel lung-specific binding motif.
The Journal of biological chemistry 2003;278(18):15473-83.
2003: Cashman John R; Camp Kathryn; Fakharzadeh Steven S; Fennessey Paul V; Hines Ronald N; Mamer Orval A; Mitchell Steven C; Nguyen George Preti; Schlenk Daniel; Smith Robert L; Tjoa Susan S; Williams David E; Yannicelli Steven
Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria.
Current drug metabolism 2003;4(2):151-70.
2003: Rettie Allan E; Tai Guoying; Veenstra David L; Farin Fred M; Srinouanprachan Sengkeo; Lin Yvonne S; Thummel Kenneth E; Hines Ronald N
CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians.
Blood 2003;101(7):2896-7.
2003: Zheng Yi-Min; Henne Kirk R; Charmley Patrick; Kim Richard B; McCarver D Gail; Cabacungan Erwin T; Hines Ronald N; Rettie Allan E
Genotyping and site-directed mutagenesis of a cytochrome P450 meander Pro-X-Arg motif critical to CYP4B1 catalysis.
Toxicology and applied pharmacology 2003;186(2):119-26.
2002: Krueger Sharon K; Williams David E; Yueh Mei-Fei; Martin Sarah R; Hines Ronald N; Raucy Judy L; Dolphin Colin T; Shephard Elizabeth A; Phillips Ian R
Genetic polymorphisms of flavin-containing monooxygenase (FMO).
Drug metabolism reviews 2002;34(3):523-32.
2002: Hines Ronald N; Hopp Kathleen A; Franco Jose; Saeian Kia; Begun Frank P
Alternative processing of the human FMO6 gene renders transcripts incapable of encoding a functional flavin-containing monooxygenase.
Molecular pharmacology 2002;62(2):320-5.
2002: Koukouritaki Sevasti B; Simpson Pippa; Yeung Catherine K; Rettie Allan E; Hines Ronald N
Human hepatic flavin-containing monooxygenases 1 (FMO1) and 3 (FMO3) developmental expression.
Pediatric research 2002;51(2):236-43.
2002: McCarver D Gail; Hines Ronald N
The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms.
The Journal of pharmacology and experimental therapeutics 2002;300(2):361-6.
2002: Hines Ronald N; McCarver D Gail
The ontogeny of human drug-metabolizing enzymes: phase I oxidative enzymes.
The Journal of pharmacology and experimental therapeutics 2002;300(2):355-60.
2002: Park Chang-Shin; Kang Ju-Hee; Chung Woon-Gye; Yi Hyun-Gyu; Pie Jae-Eun; Park Dong-Kyun; Hines R N; McCarver D G; Cha Young-Nam
Ethnic differences in allelic frequency of two flavin-containing monooxygenase 3 (FMO3) polymorphisms: linkage and effects on in vivo and in vitro FMO activities.
Pharmacogenetics 2002;12(1):77-80.
2001: Luo Z; Hines R N
Regulation of flavin-containing monooxygenase 1 expression by ying yang 1 and hepatic nuclear factors 1 and 4.
Molecular pharmacology 2001;60(6):1421-30.
2001: Hines R N; Luo Z; Cresteil T; Ding X; Prough R A; Fitzpatrick J L; Ripp S L; Falkner K C; Ge N L; Levine A; Elferink C J
Molecular regulation of genes encoding xenobiotic-metabolizing enzymes: mechanisms involving endogenous factors.
Drug metabolism and disposition: the biological fate of chemicals 2001;29(5):623-33.
2001: Delescluse C; Ledirac N; Li R; Piechocki M P; Hines R N; Gidrol X; Rahmani R
Induction of cytochrome P450 1A1 gene expression, oxidative stress, and genotoxicity by carbaryl and thiabendazole in transfected human HepG2 and lymphoblastoid cells.
Biochemical pharmacology 2001;61(4):399-407.
2000: Whetstine J R; Yueh M F; McCarver D G; Williams D E; Park C S; Kang J H; Cha Y N; Dolphin C T; Shephard E A; Phillips I R; Hines R N
Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms: detection of expressed protein in African-Americans.
Toxicology and applied pharmacology 2000;168(3):216-24.
2000: Ledirac N; Delescluse C; Lesca P; Piechocki M P; Hines R N; de Sousa G; Pralavorio M; Rahmani R
Diflubenzuron, a benzoyl-urea insecticide, is a potent inhibitor of TCDD-induced CYP1A1 expression in HepG2 cells.
Toxicology and applied pharmacology 2000;164(3):273-9.
2000: Liu L; Fan Q I; El-Zaru M R; Vanderpool K; Hines R N; Marsh J D
Regulation of DHP receptor expression by elements in the 5'-flanking sequence.
American journal of physiology. Heart and circulatory physiology 2000;278(4):H1153-62.
2000: Liu L; O'Hara D S; Cala S E; Poornima I; Hines R N; Marsh J D
Developmental regulation of the L-type calcium channel alpha1C subunit expression in heart.
Molecular and cellular biochemistry 2000;205(1-2):101-9.
1999: Linder M W; Falkner K C; Srinivasan G; Hines R N; Prough R A
Role of canonical glucocorticoid responsive elements in modulating expression of genes regulated by the arylhydrocarbon receptor.
Drug metabolism reviews 1999;31(1):247-71.
1999: Larsen-Su S; Krueger S K; Yueh M F; Lee M Y; Shehin S E; Hines R N; Williams D E
Flavin-containing monooxygenase isoform 2: developmental expression in fetal and neonatal rabbit lung.
Journal of biochemical and molecular toxicology 1999;13(3-4):187-93.
1998: McCarver D G; Byun R; Hines R N; Hichme M; Wegenek W
A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake.
Toxicology and applied pharmacology 1998;152(1):276-81.
1998: Piechocki M P; Hines R N
Functional characterization of the human CYP1A1 negative regulatory element: modulation of Ah receptor mediated transcriptional activity.
Carcinogenesis 1998;19(5):771-80.
1997: Luo Z; Hines R N
Further characterization of the major and minor rabbit FMO1 promoters and identification of both positive and negative distal regulatory elements.
Archives of biochemistry and biophysics 1997;346(1):96-104.
1997: Rasheed A; Hines R N; McCarver-May D G
Variation in induction of human placental CYP2E1: possible role in susceptibility to fetal alcohol syndrome?
Toxicology and applied pharmacology 1997;144(2):396-400.
1996: Luo Z; Hines R N
Identification of multiple rabbit flavin-containing monooxygenase form 1 (FMO1) gene promoters and observation of tissue-specific DNase I hypersensitive sites.
Archives of biochemistry and biophysics 1996;336(2):251-60.
1996: Shehin-Johnson S E; Palmer K C; Hines R N
Identification of tissue-specific DNase I hypersensitive sites in the rabbit flavin-containing monooxygenase form 2 gene.
Drug metabolism and disposition: the biological fate of chemicals 1996;24(8):891-8.
1995: Schlenk D; Peters L; Shehin-Johnson S; Hines R N; Livingstone D R
Differential expression and activity of flavin-containing monooxygenases in euryhaline and stenohaline flatfishes indicates potential osmoregulatory role.
Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology 1995;112(2):179-86.
1995: Boucher P D; Piechocki M P; Hines R N
Partial characterization of the human CYP1A1 negatively acting transcription factor and mutational analysis of its cognate DNA recognition sequence.
Molecular and cellular biology 1995;15(9):5144-51.
1995: Lee M Y; Smiley S; Kadkhodayan S; Hines R N; Williams D E
Developmental regulation of flavin-containing monooxygenase (FMO) isoforms 1 and 2 in pregnant rabbit.
Chemico-biological interactions 1995;96(1):75-85.
1995: Shehin-Johnson S E; Williams D E; Larsen-Su S; Stresser D M; Hines R N
Tissue-specific expression of flavin-containing monooxygenase (FMO) forms 1 and 2 in the rabbit.
The Journal of pharmacology and experimental therapeutics 1995;272(3):1293-9.
1995: Boucher P D; Hines R N
In vitro binding and functional studies comparing the human CYP1A1 negative regulatory element with the orthologous sequences from rodent genes.
Carcinogenesis 1995;16(2):383-92.
1995: Peters L D; Livingstone D R; Shenin-Johnson S; Hines R N; Schlenk D
Characterization of hepatic flavin monooxygenase from the marine teleost turbot (Scophthalmus maximus L.).
Xenobiotica; the fate of foreign compounds in biological systems 1995;25(2):121-31.
1994: Thomsen J S; Wang X; Hines R N; Safe S
Restoration of aryl hydrocarbon (Ah) responsiveness in MDA-MB-231 human breast cancer cells by transient expression of the estrogen receptor.
Carcinogenesis 1994;15(5):933-7.
1994: Piechocki M P; Hines R N
Oligonucleotide design and optimized protocol for site-directed mutagenesis.
BioTechniques 1994;16(4):702-7.
1994: Hines R N; Cashman J R; Philpot R M; Williams D E; Ziegler D M
The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.
Toxicology and applied pharmacology 1994;125(1):1-6.
1994: Lawton M P; Cashman J R; Cresteil T; Dolphin C T; Elfarra A A; Hines R N; Hodgson E; Kimura T; Ozols J; Phillips I R
A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities.
Archives of biochemistry and biophysics 1994;308(1):254-7.
1993: States J C; Quan T; Hines R N; Novak R F; Runge-Morris M
Expression of human cytochrome P450 1A1 in DNA repair deficient and proficient human fibroblasts stably transformed with an inducible expression vector.
Carcinogenesis 1993;14(8):1643-9.
1993: Boucher P D; Ruch R J; Hines R N
Specific nuclear protein binding to a negative regulatory element on the human CYP1A1 gene.
The Journal of biological chemistry 1993;268(23):17384-91.
1992: Hines R N; O'Connor K C; Vella G; Warren W
Large-scale purification of plasmid DNA by anion-exchange high-performance liquid chromatography.
BioTechniques 1992;12(3):430-4.
1991: Thomsen J S; Nissen L; Stacey S N; Hines R N; Autrup H
Differences in 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible CYP1A1 expression in human breast carcinoma cell lines involve altered trans-acting factors.
European journal of biochemistry / FEBS 1991;197(3):577-82.
1990: Pasanen M; Haaparanta T; Sundin M; Sivonen P; Vakakangas K; Raunio H; Hines R; Gustafsson J A; Pelkonen O
Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities.
Toxicology 1990;62(2):175-87.
1989: McLemore T L; Adelberg S; Czerwinski M; Hubbard W C; Yu S J; Storeng R; Wood T G; Hines R N; Boyd M R
Altered regulation of the cytochrome P4501A1 gene: novel inducer-independent gene expression in pulmonary carcinoma cell lines.
Journal of the National Cancer Institute 1989;81(23):1787-94.
1989: Mathis J M; Houser W H; Bresnick E; Cidlowski J A; Hines R N; Prough R A; Simpson E R
Glucocorticoid regulation of the rat cytochrome P450c (P450IA1) gene: receptor binding within intron I.
Archives of biochemistry and biophysics 1989;269(1):93-105.
1988: Tiesman J; Meyer A; Hines R N; Rizzino A
Production of growth factors related to fibroblast growth factor and platelet-derived growth factor by human embryonal carcinoma cells.
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1988;24(12):1209-16.
1988: Hines R N; Mathis J M; Jacob C S
Identification of multiple regulatory elements on the human cytochrome P450IA1 gene.
Carcinogenesis 1988;9(9):1599-605.
1988: Pasanen M; Stacey S; Lykkesfeldt A; Briand P; Hines R; Autrup H
Induction of cytochrome P-450IA1 gene expression in human breast tumour cell lines.
Chemico-biological interactions 1988;66(3-4):223-32.
1987: Houser W H; Cunningham C K; Hines R N; Schaeffer W I; Bresnick E
Interaction of the 4 S polycyclic aromatic hydrocarbon-binding protein with the cytochrome P-450c gene.
Archives of biochemistry and biophysics 1987;259(1):215-23.
1987: Iversen P L; Heiger W J; Bresnick E; Hines R N
Structural details of the human cytochrome P-450c gene.
Archives of biochemistry and biophysics 1987;256(1):397-401.
1987: Koser P L; Faletto M B; Bansal S K; Caballes L; Bresnick E; Hines R N; Gurtoo H L
Aflatoxin B1-4-hydroxylase is associated with cytochrome P3-450 in C57BL/6 mouse liver.
Biochemical and biophysical research communications 1987;142(3):872-8.
1986: Mathis J M; Prough R A; Hines R N; Bresnick E; Simpson E R
Regulation of cytochrome P-450c by glucocorticoids and polycyclic aromatic hydrocarbons in cultured fetal rat hepatocytes.
Archives of biochemistry and biophysics 1986;246(1):439-48.
1986: Iversen P L; Hines R N; Bresnick E
The molecular biology of the polycyclic aromatic hydrocarbon inducible cytochrome P-450; the past is prologue.
BioEssays : news and reviews in molecular, cellular and developmental biology 1986;4(1):15-9.
1985: Houser W H; Hines R N; Bresnick E
Implication of the "4S" polycyclic aromatic hydrocarbon binding protein in the transregulation of rat cytochrome P-450c expression.
Biochemistry 1985;24(26):7839-45.
1985: Foldes R L; Hines R N; Ho K L; Shen M L; Nagel K B; Bresnick E
3-Methylcholanthrene-induced expression of the cytochrome P-450c gene.
Archives of biochemistry and biophysics 1985;239(1):137-46.
1985: Hines R N; Levy J B; Conrad R D; Iversen P L; Shen M L; Renli A M; Bresnick E
Gene structure and nucleotide sequence for rat cytochrome P-450c.
Archives of biochemistry and biophysics 1985;237(2):465-76.
1984: Bresnick E; Foldes R; Hines R N
Induction of cytochrome P450 by xenobiotics.
Pharmacological reviews 1984;36(2 Suppl):43S-51S.
1983: Omiecinski C J; Hines R N; Foldes R L; Levy J B; Bresnick E
Molecular induction by phenobarbital of a rat hepatic form of cytochrome P-450: expression of a 4-kilobase messenger RNA.
Archives of biochemistry and biophysics 1983;227(2):478-93.
1982: Wiebkin P; Sieg M S; Nelson R E; Hines R N; Prough R A
Inhibition of metabolism-mediated cytotoxicity by 1,1-disubstituted hydrazines in mouse mastocytoma (line P815) cells.
Biochemical pharmacology 1982;31(18):2921-8.
1981: Bresnick E; Levy J; Hines R N; Levin W; Thomas P E
The molecular cloning of cytochrome P-450c information.
Archives of biochemistry and biophysics 1981;212(2):501-7.
1981: Prough R A; Freeman P C; Hines R N
The oxidation of hydrazine derivatives catalyzed by the purified liver microsomal FAD-containing monooxygenase.
The Journal of biological chemistry 1981;256(9):4178-84.
1981: Wiebkin P; Hines R N; Nelson R E; Prough R A
Inhibition of metabolism--mediated cytotoxicity by 1,1-disubstituted hydrazines in mouse mastocytoma cells (line P815).
Advances in experimental medicine and biology 1981;136 Pt B():1067-75.
1980: Hines R N; Prough R A
The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
The Journal of pharmacology and experimental therapeutics 1980;214(1):80-6.
1977: Hines R N; Wenner C E
The role of P(i) in glycolytic inhibition of calcium ion uptake by ELD ascites tumor cells.
Biochimica et biophysica acta 1977;465(2):391-9.

Sign-in to see more